Section Arrow
AMLX.NASDAQ
- Amylyx Pharmaceuticals
Quotes are at least 15-min delayed:2025/12/19 07:20 EST
Pre Market
Last
 12
+0.08 (+0.67%)
Bid
11.87
Ask
13.5
High 12.9 
Low 11.8 
Volume 9.02K 
Regular Hours (Closed)
Last
 11.92
+0.05 (+0.42%)
Day High 
12.165 
Prev. Close
11.87 
1-M High
15.3899 
Volume 
1.38M 
Bid
11.87
Ask
13.5
Day Low
11.785 
Open
11.93 
1-M Low
11.69 
Market Cap 
1.30B 
Currency 美元 
P/E 2.6 
%Yield -- 
10-SMA 13.17 
20-SMA 13.81 
50-SMA 13.85 
52-W High 16.96 
52-W Low 2.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.79/-1.58
Enterprise Value
1.30B
Balance Sheet
Book Value Per Share
3.02
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
87.37M
Operating Revenue Per Share
1.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ATHAAthira Pharma Inc.6.72+2.585+62.52%-- 
Pre Market 6.46 -0.26 -3.87%
RXRXRecursion Pharmaceuticals4.44-0.24-5.13%-- 
Pre Market 4.555 +0.115 +2.59%
MRNAModerna30.95+0.44+1.44%-- 
Pre Market 30.99 +0.04 +0.13%
INSMInsmed Incorporated166.55-31.91-16.08%-- 
Pre Market 166.5 -0.05 -0.03%
AKTXAkari Therapeutics plc0.245-0.0055-2.20%-- 
Pre Market 0.2499 +0.0049 +2.00%
Industry overview quotes are at least 15 minutes delayed
Business Description
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.